Showing results (51-60 of 156) with videos related to
Sort By:
Pageof 16
Medecine Et Maladies Infectieuses|November 11, 2006
[Mutation window for the "pneumococcus-fluoroquinolone" couple. Contribution of experimental models]P Chavanet, D CroisierAIDS (London, England)|March 31, 1998
Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients?L Piroth, M Duong, C Quantin, et al.The Journal of Antimicrobial Chemotherapy|February 1, 1990
A multicentre, open, clinical trial of a new intravenous formulation of fusidic acid in severe staphylococcal infectionsH PortierClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 18, 2002
Exercise stress testing for detection of silent myocardial ischemia in human immunodeficiency virus-infected patients receiving antiretroviral therapyM Duong, Y Cottin, L Piroth, et al.Annales De Cardiologie Et D'Angeiologie|January 13, 2004
[Is there an increased risk for cardiovascular disease in HIV-infected patients on antiretroviral therapy?]M Duong, Y Cottin, M Froidure, et al.La Revue De Medecine Interne|January 15, 2019
[Influenza infection: An update for clinicians]M Blot, P Chavanet, L PirothPresse Medicale (Paris, France : 1983)|October 26, 1988
[Evaluation of ceftazidime treatment in septicemia expert systems]H Portier, C BeuscartBiopharmaceutics & Drug Disposition|August 1, 1994
The penetration of amphotericin B from an Intralipid formulation into fibrin loci in a rabbit model of candidiasisM Bouley, M Tod, P Chavanet, et al.La Revue Du Praticien|February 1, 1992
[Current status on the epidemiology of acute pharyngitis and post-streptococcal syndromes]P Gehanno, H Portier, P LonguetPathologie-Biologie|March 1, 1996
[Treatment of bacterial pneumonias with cefuroxime-axetil. Predictive value of measurement of the in vitro susceptibility]R Cluzel, H Portier, J ModaïPageof 16